At diagnosis, approximately 40% of patients had tumors within HAR, and 33.7% experienced recurrent tumors near the hippocampus.
He ZY et al. (56) conducted a retrospective cohort analysis to compare the efficacy of concurrent EGFR-TKIs and whole brain radiotherapy (WBRT) against EGFR-TKIs alone in patients with advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback